Last reviewed · How we verify

NCT03496090

Randomized Multicentric Trial to Evaluate a Free Diet With a Progressive Diet in the Treatment of Acute Diverticulitis (DIVERDIET)

Completed NA Last updated 19 August 2019
What this trial tests

NA trial testing Free diet in Diverticulitis in 134 participants. Completed in 16 April 2019.

Timeline
16 April 2018
Primary endpoint
31 January 2019
16 April 2019

Quick facts

Lead sponsorHospital General Universitario Reina Sofía de Murcia
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment134
Start date16 April 2018
Primary completion31 January 2019
Estimated completion16 April 2019
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Hospital General Universitario Reina Sofía de Murcia

Who can join

18 and older, any sex, with Diverticulitis or Acute Diverticulitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Phase III trial is designed to demonstrate the non-inferiority of a free diet versus a progressive diet in the treatment of acute diverticulitis (AD) without complications. In this study, the effectiveness of the short-term free diet is evaluated, as well as its safety and the quality of life that is perceived in front of the progressive diet.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Free diet

Trials testing the same drug.

Other recruiting trials for Diverticulitis

Currently open trials in the same condition.

Other Hospital General Universitario Reina Sofía de Murcia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03496090.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing